Is Invitae Stock a Buy Now?
Invitae (NYSE: NVTA) shares have plummeted more than 80% this year. The genetic testing company has grown revenue over the years, but it hasn't been able to turn that revenue into profit. Instead, it's burned through cash -- and left investors wondering when and if the company can make it to profitability.